Roivant Sciences (ROIV) News Today $11.37 +0.29 (+2.62%) Closing price 06/10/2025 04:00 PM EasternExtended Trading$11.37 +0.00 (+0.01%) As of 05:33 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ROIV Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Roivant Sciences à la conférence Goldman Sachs : focus sur l’exécution stratégiqueJune 10 at 8:42 PM | fr.investing.comGAMMA Investing LLC Has $6.49 Million Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV)GAMMA Investing LLC lifted its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 1,746.5% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 65,514 shares of the company'June 10 at 3:32 AM | marketbeat.comRoivant and Priovant to Host Investor Video Conference at 1:00 PM ET on Tuesday, June 17 on Brepocitinib and the Unmet Medical Need in DermatomyositisJune 9 at 4:05 PM | globenewswire.comVivek Ramaswamy Sells 547,430 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) StockJune 8 at 4:21 AM | americanbankingnews.comRoivant Sciences Ltd. (NASDAQ:ROIV) Major Shareholder Vivek Ramaswamy Sells 200,800 SharesJune 7, 2025 | insidertrades.comRoivant Sciences Ltd. (NASDAQ:ROIV) Major Shareholder Sells $2,246,952.00 in StockRoivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) major shareholder Vivek Ramaswamy sold 200,800 shares of the business's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $11.19, for a total transaction of $2,246,952.00. Following the completion of the sale, the insider now directly owns 38,426,381 shares of the company's stock, valued at approximately $429,991,203.39. This trade represents a 0.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Large shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.June 6, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Major Shareholder Vivek Ramaswamy Sells 547,430 SharesRoivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) major shareholder Vivek Ramaswamy sold 547,430 shares of the business's stock in a transaction dated Wednesday, June 4th. The stock was sold at an average price of $11.34, for a total transaction of $6,207,856.20. Following the sale, the insider now owns 38,627,181 shares in the company, valued at $438,032,232.54. This trade represents a 1.40% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Major shareholders that own at least 10% of a company's shares are required to disclose their sales and purchases with the SEC.June 6, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) COO Sells $4,801,302.54 in StockRoivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) COO Eric Venker sold 433,722 shares of the business's stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $11.07, for a total value of $4,801,302.54. Following the completion of the sale, the chief operating officer now directly owns 1,243,475 shares in the company, valued at $13,765,268.25. This trade represents a 25.86% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.June 5, 2025 | marketbeat.comInsider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) COO Sells 566,278 Shares of StockRoivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) COO Eric Venker sold 566,278 shares of the business's stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $11.22, for a total value of $6,353,639.16. Following the completion of the transaction, the chief operating officer now directly owns 1,462,223 shares in the company, valued at $16,406,142.06. The trade was a 27.92% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.June 5, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) COO Sells $4,801,302.54 in StockJune 5, 2025 | insidertrades.comCalifornia State Teachers Retirement System Acquires 37,982 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)California State Teachers Retirement System boosted its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 10.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 391,703 shares of the company's stock after pJune 4, 2025 | marketbeat.comJefferies Financial Group Inc. Makes New Investment in Roivant Sciences Ltd. (NASDAQ:ROIV)Jefferies Financial Group Inc. purchased a new position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 40,000 shares of the company's stock, valued at approximately $473,000. Several other instituJune 1, 2025 | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $324,000 Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. trimmed its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 66.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 28,374 shares of the cJune 1, 2025 | marketbeat.comRoivant Sciences (NASDAQ:ROIV) Trading 5.5% Higher - Here's WhyRoivant Sciences (NASDAQ:ROIV) Shares Up 5.5% - Should You Buy?May 30, 2025 | marketbeat.comRoivant Sciences (NASDAQ:ROIV) Releases Quarterly Earnings Results, Misses Expectations By $0.15 EPSRoivant Sciences (NASDAQ:ROIV - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.31) EPS for the quarter, missing analysts' consensus estimates of ($0.16) by ($0.15). Roivant Sciences had a negative net margin of 119.54% and a negative return on equity of 14.05%. During the same period last year, the company posted ($0.23) EPS.May 30, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Q4 2024 Earnings Call TranscriptMay 30, 2025 | insidermonkey.comWhat To Expect From Roivant Sciences Ltd (ROIV) Q4 2025 EarningsMay 30, 2025 | finance.yahoo.comWhy Roivant Sciences Ltd. (ROIV) Surged On ThursdayMay 30, 2025 | msn.comRoivant Sciences Reports Progress and Financial ResultsMay 30, 2025 | tipranks.comH.C. Wainwright maintains $18 target on Roivant Sciences stockMay 29, 2025 | investing.comRoivant Sciences Earnings Call: Balancing Growth and ChallengesMay 29, 2025 | tipranks.comRoivant Sciences Ltd. (ROIV) Q4 2024 Earnings Call TranscriptMay 29, 2025 | seekingalpha.comRoivant Sciences Ltd. 2024 Q4 - Results - Earnings Call PresentationMay 29, 2025 | seekingalpha.comRoivant Sciences' (ROIV) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $18.00 price target on shares of Roivant Sciences in a report on Wednesday.May 29, 2025 | marketbeat.comRoivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025, and Provides Business UpdateMay 29, 2025 | globenewswire.comH.C. Wainwright maintient son objectif de 18€ pour l’action Roivant SciencesMay 28, 2025 | fr.investing.comRoivant Sciences Ltd. (NASDAQ:ROIV) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 4.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. ThMay 28, 2025 | marketbeat.comRoivant Sciences (ROIV) Projected to Post Quarterly Earnings on ThursdayRoivant Sciences (NASDAQ:ROIV) will be releasing its Q4 2025 earnings before the market opens on Thursday, May 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-29-roivant-sciences-ltd-stock/)May 24, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) COO Eric Venker Sells 100,000 SharesMay 23, 2025 | insidertrades.comZimmer Partners LP Makes New Investment in Roivant Sciences Ltd. (NASDAQ:ROIV)Zimmer Partners LP bought a new stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 252,900 shares of the company's stock, valued at aMay 23, 2025 | marketbeat.comNuveen Asset Management LLC Decreases Stake in Roivant Sciences Ltd. (NASDAQ:ROIV)Nuveen Asset Management LLC reduced its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 5.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,013,533 shares of the coMay 23, 2025 | marketbeat.comWoodline Partners LP Sells 2,554,528 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)Woodline Partners LP decreased its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 29.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,131,948 shares of the company's stMay 22, 2025 | marketbeat.comBank of America Corp DE Cuts Stake in Roivant Sciences Ltd. (NASDAQ:ROIV)Bank of America Corp DE lessened its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 19.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,718,269 shares of the company's stock after selling 415,363 sharesMay 22, 2025 | marketbeat.comVestal Point Capital LP Buys Shares of 1,250,000 Roivant Sciences Ltd. (NASDAQ:ROIV)Vestal Point Capital LP bought a new stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 1,250,000 shares of the company's stock, valued at approximately $14,788,0May 21, 2025 | marketbeat.comOMERS ADMINISTRATION Corp Decreases Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)OMERS ADMINISTRATION Corp decreased its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 50.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 50,800 shares of the company's stock after selling 50,800 sMay 21, 2025 | marketbeat.comTyro Capital Management LLC Has $24.94 Million Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV)Tyro Capital Management LLC lifted its stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 20.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,108,283 shares of the company's stock afMay 20, 2025 | marketbeat.comRafferty Asset Management LLC Increases Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)Rafferty Asset Management LLC grew its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 8.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 722,429 shares of the company's stock afterMay 19, 2025 | marketbeat.comJefferies Financial Group Inc. Invests $473,000 in Roivant Sciences Ltd. (NASDAQ:ROIV)Jefferies Financial Group Inc. bought a new position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 40,000 shares of the company's stock, valued at approximately $473,000. A number of other institutionalMay 19, 2025 | marketbeat.comDimensional Fund Advisors LP Sells 71,627 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)Dimensional Fund Advisors LP lessened its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 35.3% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 131,314 shares of the company's stock after selling 71,627 shares during the period. DimMay 18, 2025 | marketbeat.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Relmada Therapeutics (RLMD) and Roivant Sciences (ROIV)May 17, 2025 | theglobeandmail.comRoivant Sciences Ltd. (NASDAQ:ROIV) Shares Sold by PointState Capital LPPointState Capital LP lessened its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 19.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,297,449 shares of the company's stock afteMay 17, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Holdings Trimmed by Prosight Management LPProsight Management LP trimmed its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 12.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,500,000 shares of the company's stock after selling 221,51May 17, 2025 | marketbeat.comPatient Square Capital LP Has $147.64 Million Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)Patient Square Capital LP increased its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 2.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,480,000 shares of the company's stock after acquiringMay 16, 2025 | marketbeat.comMaven Securities LTD Reduces Stake in Roivant Sciences Ltd. (NASDAQ:ROIV)Maven Securities LTD decreased its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 81.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 75,000 shares of the company's stock afteMay 16, 2025 | marketbeat.com468,010 Shares in Roivant Sciences Ltd. (NASDAQ:ROIV) Acquired by BNP Paribas Financial MarketsBNP Paribas Financial Markets bought a new stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 468,010 shares of the company's stock, valued at approximately $5,537,00May 16, 2025 | marketbeat.comRoivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025 and Provide Business Update on Thursday, May 29, 2025May 15, 2025 | globenewswire.comRoivant Sciences à la conférence BofA Securities : Changements stratégiques et focus sur les litigesMay 15, 2025 | fr.investing.comOCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 32,329 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 22.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 179,266 shares ofMay 15, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Reduces Stake in Roivant Sciences Ltd. (NASDAQ:ROIV)Schonfeld Strategic Advisors LLC reduced its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 79.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 71,400 shares of the company's stock after selling 283,May 11, 2025 | marketbeat.comNorthern Trust Corp Boosts Stake in Roivant Sciences Ltd. (NASDAQ:ROIV)Northern Trust Corp lifted its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 23.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,448,082 shares of the company's stock after acquiring an additional 6May 11, 2025 | marketbeat.com Get Roivant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ROIV and its competitors with MarketBeat's FREE daily newsletter. Email Address ROIV Media Mentions By Week ROIV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ROIV News Sentiment▼0.481.01▲Average Medical News Sentiment ROIV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ROIV Articles This Week▼167▲ROIV Articles Average Week Get Roivant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ROIV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BNTX News Today ONC News Today TEVA News Today ITCI News Today GMAB News Today SMMT News Today RDY News Today ASND News Today MRNA News Today VTRS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ROIV) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roivant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Roivant Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ROIV Stock Free ROIV Stock Alerts